Impact of Sacubitril –Valsartan Treatment on Diastolic Function in Patients with Heart Failure and Reduced Ejection Fraction

ConclusionsIn addition to an improvement in systolic function parameters, patients with HFrEF receiving S –V improved their diastolic function. This echocardiographic improvement is particularly relevant in those patients with better NYHA class at 6-month follow-up.

http://link.springer.com/10.1007/s40292-021-00437-x

Source: High Blood Pressure and Cardiovascular Prevention - February 18, 2021 Category: Cardiology Source Type: research